Oxyntomodulin peptide analogue

PK201001023A0Active Publication Date: 2010-12-27ELI LILLY & CO
0 Cites 0 Cited by

Patent Information

Application Number
PK201001023
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Filing Date
2010-12-09
Publication Date
2010-12-27
Patent Text Reader

Abstract

The present invention provides an Oxyntomodulin peptide analogue comprising the amino acid sequence: His-(Aib)-Gln-Gly-Thr-Phe-Thr-5 Ser-Asp-TyrSer-Lys-Tyr-Leu-Asp-Ser-Lys-Lys-Ala-Gln-GluPhe-Val-Gln-Trp-Leu-Leu-Asn-(Aib)-Gly-ArgAsn-Arg-Asn-Asn-Ile-Ala-Xaa38-Xaa39 (SEQ ID NO:5) wherein Xaa38 is Cys, Cys-PEG, or is absent; Xaa 39 is Cys, Cys-PEG, or is absent; and wherein the C-terminal amino acid is optinally amidated. The oxyntomodulin peptide analogue may be useful in the treatment of diabetes and / or obesity.
Need to check novelty before this filing date? Find Prior Art